{"id":"https://openalex.org/W7223701460","doi":"https://doi.org/10.3389/fimmu.2026.1936870","title":"Safety and efficacy of intrathecal methotrexate in severe anti-NMDAR encephalitis: a single-institution retrospective study","display_name":"Safety and efficacy of intrathecal methotrexate in severe anti-NMDAR encephalitis: a single-institution retrospective study","publication_year":2026,"publication_date":"2026-10-26","ids":{"openalex":"https://openalex.org/W7223701460","doi":"https://doi.org/10.3389/fimmu.2026.1936870"},"language":"en","primary_location":{"id":"doi:10.3389/fimmu.2026.1936870","doi":"https://doi.org/10.3389/fimmu.2026.1936870","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fimmu.2026.1936870","pdf_url":"https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2026.1936870/pdf","source":{"id":"https://openalex.org/S2595292759","display_name":"Frontiers in Immunology","issn_l":"1664-3224","issn":["1664-3224"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Immunology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2026.1936870/pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5074879727","display_name":"Minghui Tuo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210120234","display_name":"Zhongnan Hospital of Wuhan University","ror":"https://ror.org/01v5mqw79","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210120234"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Minghui Tuo","raw_affiliation_strings":["Department of Neurology, Wuhan Zhongnan Hospital of Wuhan University","Hubei Provincial Clinical Research Center for Dementia and Cognitive Impairment"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurology, Wuhan Zhongnan Hospital of Wuhan University","institution_ids":["https://openalex.org/I4210120234"]},{"raw_affiliation_string":"Hubei Provincial Clinical Research Center for Dementia and Cognitive Impairment","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5159702088","display_name":"Jiabin Fang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210093544","display_name":"Wuhan Puai Hospital","ror":"https://ror.org/00qavst65","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210093544"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Jiabin Fang","raw_affiliation_strings":["Department of Neurology, Wuhan Fourth Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurology, Wuhan Fourth Hospital","institution_ids":["https://openalex.org/I4210093544"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064885251","display_name":"\u8303\u5143\u817e","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210120234","display_name":"Zhongnan Hospital of Wuhan University","ror":"https://ror.org/01v5mqw79","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210120234"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Yuanteng Fan","raw_affiliation_strings":["Department of Neurology, Wuhan Zhongnan Hospital of Wuhan University","Hubei Provincial Clinical Research Center for Dementia and Cognitive Impairment"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurology, Wuhan Zhongnan Hospital of Wuhan University","institution_ids":["https://openalex.org/I4210120234"]},{"raw_affiliation_string":"Hubei Provincial Clinical Research Center for Dementia and Cognitive Impairment","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5159634940","display_name":"Yan Xu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210120234","display_name":"Zhongnan Hospital of Wuhan University","ror":"https://ror.org/01v5mqw79","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210120234"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Yan Xu","raw_affiliation_strings":["Department of Neurology, Wuhan Zhongnan Hospital of Wuhan University","Hubei Provincial Clinical Research Center for Dementia and Cognitive Impairment"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurology, Wuhan Zhongnan Hospital of Wuhan University","institution_ids":["https://openalex.org/I4210120234"]},{"raw_affiliation_string":"Hubei Provincial Clinical Research Center for Dementia and Cognitive Impairment","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5064885251","https://openalex.org/A5159634940"],"corresponding_institution_ids":["https://openalex.org/I4210120234"],"apc_list":{"value":3150,"currency":"CHF","value_usd":3801},"apc_paid":{"value":3150,"currency":"CHF","value_usd":3801},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.81786526,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"17","issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11627","display_name":"Autoimmune Neurological Disorders and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11627","display_name":"Autoimmune Neurological Disorders and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11735","display_name":"Peripheral Neuropathies and Disorders","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11730","display_name":"Autoimmune Bullous Skin Diseases","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/anti-nmda-receptor-encephalitis","display_name":"anti-NMDA receptor encephalitis","score":0.9539999961853027},{"id":"https://openalex.org/keywords/intrathecal-methotrexate","display_name":"intrathecal methotrexate","score":0.9919999837875366},{"id":"https://openalex.org/keywords/autoimmune-encephalitis","display_name":"autoimmune encephalitis","score":0.9959999918937683},{"id":"https://openalex.org/keywords/immunomodulatory-therapy","display_name":"immunomodulatory therapy","score":0.8130000233650208},{"id":"https://openalex.org/keywords/treatment-escalation","display_name":"treatment escalation","score":0.8410000205039978},{"id":"https://openalex.org/keywords/treatment-timing","display_name":"treatment timing","score":0.6769999861717224},{"id":"https://openalex.org/keywords/neurotoxicity","display_name":"neurotoxicity","score":0.6589999794960022},{"id":"https://openalex.org/keywords/antibody-titers","display_name":"antibody titers","score":0.6269999742507935},{"id":"https://openalex.org/keywords/functional-outcome","display_name":"functional outcome","score":0.515999972820282}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9588000178337097},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.7177000045776367},{"id":"https://openalex.org/C2781059491","wikidata":"https://www.wikidata.org/wiki/Q422232","display_name":"Methotrexate","level":2,"score":0.7157999873161316},{"id":"https://openalex.org/C2781460105","wikidata":"https://www.wikidata.org/wiki/Q16918461","display_name":"Autoimmune encephalitis","level":4,"score":0.70660001039505},{"id":"https://openalex.org/C83455156","wikidata":"https://www.wikidata.org/wiki/Q199615","display_name":"Encephalitis","level":3,"score":0.6306999921798706},{"id":"https://openalex.org/C2780931571","wikidata":"https://www.wikidata.org/wiki/Q568775","display_name":"Modified Rankin Scale","level":4,"score":0.559499979019165},{"id":"https://openalex.org/C157820659","wikidata":"https://www.wikidata.org/wiki/Q1320251","display_name":"Intrathecal","level":2,"score":0.450300008058548},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.427700012922287},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.4171000123023987},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.4129999876022339},{"id":"https://openalex.org/C2779651940","wikidata":"https://www.wikidata.org/wiki/Q54196","display_name":"Cerebrospinal fluid","level":2,"score":0.4059999883174896},{"id":"https://openalex.org/C2781393001","wikidata":"https://www.wikidata.org/wiki/Q139032","display_name":"Ommaya reservoir","level":3,"score":0.3614000082015991},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.321399986743927},{"id":"https://openalex.org/C23131810","wikidata":"https://www.wikidata.org/wiki/Q818574","display_name":"Observational study","level":2,"score":0.319599986076355},{"id":"https://openalex.org/C81182388","wikidata":"https://www.wikidata.org/wiki/Q353963","display_name":"Complication","level":2,"score":0.30730000138282776},{"id":"https://openalex.org/C205545832","wikidata":"https://www.wikidata.org/wiki/Q17156455","display_name":"Young adult","level":2,"score":0.3043000102043152},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.30219998955726624},{"id":"https://openalex.org/C22889606","wikidata":"https://www.wikidata.org/wiki/Q2166189","display_name":"Antibody titer","level":4,"score":0.2849999964237213},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.2784000039100647},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.26589998602867126},{"id":"https://openalex.org/C2779281540","wikidata":"https://www.wikidata.org/wiki/Q5062122","display_name":"Central nervous system disease","level":2,"score":0.2646999955177307},{"id":"https://openalex.org/C32611913","wikidata":"https://www.wikidata.org/wiki/Q2166189","display_name":"Titer","level":3,"score":0.2549999952316284}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.3389/fimmu.2026.1936870","doi":"https://doi.org/10.3389/fimmu.2026.1936870","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fimmu.2026.1936870","pdf_url":"https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2026.1936870/pdf","source":{"id":"https://openalex.org/S2595292759","display_name":"Frontiers in Immunology","issn_l":"1664-3224","issn":["1664-3224"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Immunology","raw_type":"journal-article"},{"id":"pmh:oai:doaj.org/article:9c15876d081c419aa996b6a4f58cce1e","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/9c15876d081c419aa996b6a4f58cce1e","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Immunology, Vol 17 (2026)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3389/fimmu.2026.1936870","doi":"https://doi.org/10.3389/fimmu.2026.1936870","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fimmu.2026.1936870","pdf_url":"https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2026.1936870/pdf","source":{"id":"https://openalex.org/S2595292759","display_name":"Frontiers in Immunology","issn_l":"1664-3224","issn":["1664-3224"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Immunology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7223701460.pdf","grobid_xml":"https://content.openalex.org/works/W7223701460.grobid-xml"},"referenced_works_count":31,"referenced_works":["https://openalex.org/W1988612394","https://openalex.org/W2051552021","https://openalex.org/W2098001563","https://openalex.org/W2134741840","https://openalex.org/W2280783985","https://openalex.org/W2767293502","https://openalex.org/W2782996650","https://openalex.org/W2786074788","https://openalex.org/W2791304973","https://openalex.org/W2892945625","https://openalex.org/W2908950783","https://openalex.org/W2956177188","https://openalex.org/W2983299205","https://openalex.org/W3083565327","https://openalex.org/W3094037411","https://openalex.org/W3116680647","https://openalex.org/W3134115353","https://openalex.org/W3157301409","https://openalex.org/W3185087081","https://openalex.org/W3209129847","https://openalex.org/W4289522769","https://openalex.org/W4313519520","https://openalex.org/W4372221730","https://openalex.org/W4383553939","https://openalex.org/W4391207745","https://openalex.org/W4404650995","https://openalex.org/W4404900054","https://openalex.org/W4407908013","https://openalex.org/W4408846296","https://openalex.org/W4409785919","https://openalex.org/W4415566175"],"related_works":["https://openalex.org/W2782996650","https://openalex.org/W4389460545","https://openalex.org/W4383553939","https://openalex.org/W4392515386","https://openalex.org/W3209129847","https://openalex.org/W2951042211","https://openalex.org/W1523836549","https://openalex.org/W2899243098","https://openalex.org/W1583322239","https://openalex.org/W4389409681"],"abstract_inverted_index":{"Background":[0],"Anti-N-methyl-D-aspartate":[1],"receptor":[2],"(anti-NMDAR)":[3],"encephalitis":[4,14,79],"is":[5,43],"one":[6,44],"of":[7,12,45,58,63,133,166,269,290],"the":[8,46,54,141,177,188,197,240,273,284],"most":[9],"common":[10],"forms":[11],"autoimmune":[13],"(AE).":[15],"Most":[16],"cases":[17,62],"can":[18],"achieve":[19],"clinical":[20,99,138],"relief":[21,139],"with":[22,76,146,222],"first-":[23],"and":[24,35,56,93,110,120,156,164,234,256,266,287],"second-line":[25],"immunotherapies,":[26],"while":[27],"approximately":[28],"25%":[29],"are":[30,279],"resistant":[31],"to":[32,52,154,160,211,281],"these":[33],"immunotherapies":[34],"require":[36],"further":[37],"immunomodulatory":[38],"therapy.":[39],"Intrathecal":[40],"methotrexate":[41],"(IT-MTX)":[42],"escalation":[47,259],"treatments.":[48],"This":[49],"study":[50],"aimed":[51],"analyze":[53],"safety":[55],"efficacy":[57],"IT-MTX":[59,82,199,216,225,251,270,291],"in":[60,88,114,150,162,173,232,239,292],"severe":[61,77,204,262,293],"anti-NMDAR":[64,78,263,294],"encephalitis.":[65,264,295],"Methods":[66],"A":[67],"retrospective":[68],"observational":[69],"analysis":[70],"was":[71,208],"performed":[72],"on":[73],"10":[74,134,167],"patients":[75,135,168,214],"who":[80,193],"received":[81],"weekly":[83],"for":[84,128,261],"4":[85],"consecutive":[86],"weeks":[87,219,227],"our":[89],"institution":[90],"between":[91],"2021":[92],"2024.":[94],"We":[95],"reviewed":[96],"patients\u2019":[97],"baseline":[98],"characteristics,":[100],"cerebrospinal":[101],"fluid":[102],"antibody":[103,174],"titers,":[104],"modified":[105],"Rankin":[106],"Scale":[107,113],"(mRS)":[108],"scores,":[109],"Clinical":[111],"Assessment":[112],"Autoimmune":[115],"Encephalitis":[116],"(CASE)":[117],"scores":[118,152,158,236],"before":[119],"after":[121,144,228],"IT-MTX.":[122,212],"The":[123],"entire":[124],"follow-up":[125,143],"observation":[126],"lasted":[127],"12":[129],"months.":[130],"Results":[131],"Nine":[132],"experienced":[136],"significant":[137,148],"at":[140,176],"12-month":[142,178],"IT-MTX,":[145],"a":[147,170,203],"decrease":[149,172],"CASE":[151,233],"(6\u201324":[153],"0-2)":[155],"mRS":[157,235],"(4\u20135":[159],"0-1)":[161],"survivors,":[163],"six":[165],"had":[169],"parallel":[171],"titers":[175],"follow-up.":[179,190],"No":[180],"IT-MTX-related":[181],"neurotoxicity":[182],"or":[183],"recurrences":[184],"were":[185,220,237],"observed":[186],"during":[187],"1-year":[189],"One":[191],"patient":[192],"did":[194],"not":[195],"complete":[196],"standard":[198],"treatment":[200],"died":[201],"from":[202],"systemic":[205],"infection,":[206],"which":[207],"considered":[209],"unrelated":[210],"When":[213],"receiving":[215,224],"within":[217],"2":[218],"compared":[221],"those":[223],">2":[226],"conventional":[229],"immunotherapy,":[230],"reductions":[231],"larger":[238],"early-treatment":[241],"group":[242],"(p":[243],"<":[244],"0.05).":[245],"Conclusion":[246],"Our":[247],"findings":[248],"suggest":[249],"that":[250],"may":[252,271],"be":[253],"an":[254],"effective":[255],"relatively":[257],"safe":[258],"option":[260],"Early":[265],"aggressive":[267],"application":[268],"improve":[272],"prognosis.":[274],"Further":[275],"large":[276],"prospective":[277],"studies":[278],"needed":[280],"better":[282],"illustrate":[283],"safety,":[285],"efficacy,":[286],"optimal":[288],"timing":[289]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2026-10-27T00:00:00"}